Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication

Antibiotics have been useful in the treatment of H. pylori-related benign and malignant gastroduodenal diseases. However, emergence of antibiotic resistance often decreases the eradication rates of H. pylori infections. Many factors have been implicated as causes of treatment failure, but the main a...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenming Wu, Yunsheng Yang, Gang Sun
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/723183
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550659381002240
author Wenming Wu
Yunsheng Yang
Gang Sun
author_facet Wenming Wu
Yunsheng Yang
Gang Sun
author_sort Wenming Wu
collection DOAJ
description Antibiotics have been useful in the treatment of H. pylori-related benign and malignant gastroduodenal diseases. However, emergence of antibiotic resistance often decreases the eradication rates of H. pylori infections. Many factors have been implicated as causes of treatment failure, but the main antibiotic resistance mechanisms described to date are due to point mutations on the bacterial chromosome, a consequence of a significantly phenotypic variation in H. pylori. The prevalence of antibiotic (e.g., clarithromycin, metronidazole, tetracycline, amoxicillin, and furazolidone) resistance varies among different countries; it appears to be partly determined by geographical factors. Since the worldwide increase in the rate of antibiotic resistance represents a problem of relevance, some studies have been performed in order to identify highly active and well-tolerated anti-H. pylori therapies including sequential, concomitant quadruple, hybrid, and quadruple therapy. These represent a promising alternatives in the effort to overcome the problem of resistance. The aim of this paper is to review the current status of antibiotic resistance in H. pylori eradication, highlighting the evolutionary processes in detail at alternative approaches to treatment in the past decade. The underlying resistance mechanisms will be also followed.
format Article
id doaj-art-d49e6fee6df84dc0bcf4088c2a6ed1eb
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-d49e6fee6df84dc0bcf4088c2a6ed1eb2025-02-03T06:06:12ZengWileyGastroenterology Research and Practice1687-61211687-630X2012-01-01201210.1155/2012/723183723183Recent Insights into Antibiotic Resistance in Helicobacter pylori EradicationWenming Wu0Yunsheng Yang1Gang Sun2Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, ChinaDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, ChinaDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, ChinaAntibiotics have been useful in the treatment of H. pylori-related benign and malignant gastroduodenal diseases. However, emergence of antibiotic resistance often decreases the eradication rates of H. pylori infections. Many factors have been implicated as causes of treatment failure, but the main antibiotic resistance mechanisms described to date are due to point mutations on the bacterial chromosome, a consequence of a significantly phenotypic variation in H. pylori. The prevalence of antibiotic (e.g., clarithromycin, metronidazole, tetracycline, amoxicillin, and furazolidone) resistance varies among different countries; it appears to be partly determined by geographical factors. Since the worldwide increase in the rate of antibiotic resistance represents a problem of relevance, some studies have been performed in order to identify highly active and well-tolerated anti-H. pylori therapies including sequential, concomitant quadruple, hybrid, and quadruple therapy. These represent a promising alternatives in the effort to overcome the problem of resistance. The aim of this paper is to review the current status of antibiotic resistance in H. pylori eradication, highlighting the evolutionary processes in detail at alternative approaches to treatment in the past decade. The underlying resistance mechanisms will be also followed.http://dx.doi.org/10.1155/2012/723183
spellingShingle Wenming Wu
Yunsheng Yang
Gang Sun
Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
Gastroenterology Research and Practice
title Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
title_full Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
title_fullStr Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
title_full_unstemmed Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
title_short Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
title_sort recent insights into antibiotic resistance in helicobacter pylori eradication
url http://dx.doi.org/10.1155/2012/723183
work_keys_str_mv AT wenmingwu recentinsightsintoantibioticresistanceinhelicobacterpylorieradication
AT yunshengyang recentinsightsintoantibioticresistanceinhelicobacterpylorieradication
AT gangsun recentinsightsintoantibioticresistanceinhelicobacterpylorieradication